Effect of ramipril on cardiovascular events in high-risk patients. Reply

被引:0
作者
Yusuf, S [1 ]
机构
[1] McMaster Univ, Hamilton, ON L8L 2X2, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:66 / 66
页数:1
相关论文
共 50 条
  • [31] Reservoir and excess pressures predict cardiovascular events in high-risk patients
    Hametner, Bernhard
    Wassertheurer, Siegfried
    Hughes, Alun D.
    Parker, Kim H.
    Weber, Thomas
    Eber, Bernd
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 171 (01) : 31 - 36
  • [32] THE INFLUENZA VACCINE-PREVENTING CARDIOVASCULAR EVENTS IN HIGH-RISK PATIENTS
    Farkouh, M. E.
    Udell, J. A.
    CARDIOLOGY, 2014, 128 : 91 - 91
  • [33] Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients
    Maiolino, Giuseppe
    Cesari, Maurizio
    Sticchi, Daniele
    Zanchetta, Mario
    Pedon, Luigi
    Antezza, Katia
    Pessina, Achille C.
    Rossi, Gian Paolo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (09) : 3333 - 3340
  • [34] Effect of evacetrapib on cardiovascular outcomes in patients with high-risk cardiovascular disease
    Aronow, Wilbert S.
    JOURNAL OF THORACIC DISEASE, 2017, 9 (07) : 1822 - 1825
  • [35] Telmisartan, ramipril, or both in patients at high risk for vascular events
    Vidt, Donald G.
    CURRENT HYPERTENSION REPORTS, 2008, 10 (05) : 343 - 344
  • [36] Telmisartan, ramipril, or both in patients at high risk for vascular events
    Dominiak, Marcin
    KARDIOLOGIA POLSKA, 2008, 66 (06) : 705 - 707
  • [37] Telmisartan, ramipril, or both in patients at high risk for vascular events
    Yusuf, Salim
    Teo, Koon K.
    Pogue, Janice
    Dyal, Leanne
    Copland, Ingrid
    Schumacher, Helmut
    Ingelheim, Boehringer
    Dagenais, Gilles
    Sleight, Peter
    Anderson, Craig
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (15) : 1547 - 1559
  • [38] Telmisartan, ramipril, or both in patients at high risk of vascular events
    Messerli, Franz H.
    Bangalore, Sripal
    Ram, Venkata S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04) : 426 - 427
  • [39] Telmisartan, ramipril, or both in patients at high risk for vascular events
    Donald G. Vidt
    Current Hypertension Reports, 2008, 10 : 343 - 344
  • [40] Beneficial effects of Ramipril on cardiovascular events in high-risk patients older than 75 years of age: Secondary outcomes from the HOPE trial
    Bosch, J
    Probstfield, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 154A - 154A